Enhancing Primary Immunodeficiency Diagnosis: Findings From Targeted Genetic Testing in a Turkish Cohort
Scandinavian Journal of Immunology · 2025
DOI: 10.1111/sji.70031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2025. Verfasst von Çiğdem Aydoğmus und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Allergy and Clinical Immunology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Genetic Testing, Primary Immunodeficiency Diseases, Immunologic Deficiency Syndromes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Jeffrey Modell Foundation.
Abstract (Originalsprache)
Primary immunodeficiency disorders (PIDDs) comprise a heterogeneous group of genetic conditions characterised by recurrent infections, immune dysregulation and increased susceptibility to malignancies. While clinical evaluation remains essential for diagnosis, genetic testing plays a pivotal role in confirming the diagnosis and guiding management. This cross‐sectional study evaluates the diagnostic yield and clinical utility of targeted gene panel testing in patients with a strong clinical suspicion of PIDDs, within the framework of the Jeffrey Modell Foundation's ‘Jeffrey's Insights’ programme. Between 2022 and 2024, 104 patients without a prior genetic diagnosis were evaluated at the Department of Paediatric Allergy and Clinical Immunology, Başakşehir Çam and Sakura City Hospital, Türkiye. In 72 of 104 patients, the identified variants were consistent with clinical phenotypes. Pathogenic or likely pathogenic variants were identified in 41.3% of patients, increasing to 57.7% when including variants of uncertain significance (VUS) with high CADD scores. Genetic findings prompted reclassification of International Union of Immunological Societies (IUIS) categories in 25% of cases. Autosomal recessive inheritance and parental consanguinity were notable, reflecting regional genetic patterns. Failure to thrive and low switched memory B cell percentages were significantly associated with confirmed genetic diagnoses, while food allergy, viral skin infections and eczema were more common in genetically undiagnosed patients. These findings support the clinical value of targeted gene panels as an effective, accessible and informative tool in the diagnosis and classification of PIDDs, enhancing precision in patient care and enabling tailored therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Allergy and Clinical Immunology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Türkiye.
- University of Health Sciences, Istanbul Haseki Training and Research Hospital, Istanbul, Türkiye.
- Gaziosmanpaşa Training and Research Hospital, Istanbul, Türkiye.
- Department of Pediatric Allergy and Clinical Immunology, Marmara University Faculty of Medicine, Istanbul, Türkiye.
- Scientific Director, Jeffrey Modell Foundation, Columbia New York Presbyterian Hospital, New York, New York, USA.
ORCID-Profile: Çiğdem Aydoğmus, Özge Türkyılmaz Uçar
Förderung
- Jeffrey Modell Foundation
Zitieren
APA
Aydoğmus, Ç., Sarıkavak, S. K., Cil, B., Uçar, Ö. T., Özdemir, P. G., Al, S., Can, S., Barış, S., & Quinn, J. (2025). Enhancing Primary Immunodeficiency Diagnosis: Findings From Targeted Genetic Testing in a Turkish Cohort. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.70031
Vancouver
Aydoğmus Ç, Sarıkavak SK, Cil B, Uçar ÖT, Özdemir PG, Al S, et al. Enhancing Primary Immunodeficiency Diagnosis: Findings From Targeted Genetic Testing in a Turkish Cohort. Scandinavian Journal of Immunology. 2025. doi:10.1111/sji.70031
BibTeX
@article{Aydomus2025,
author = {Aydoğmus, Çiğdem and Sarıkavak, Sibel Kaplan and Cil, Burcu and Uçar, Özge Türkyılmaz and Özdemir, Pinar Gökmirza and Al, Serdar and Can, Salim and Barış, Safa and Quinn, Jessica},
title = {Enhancing Primary Immunodeficiency Diagnosis: Findings From Targeted Genetic Testing in a Turkish Cohort},
journal = {Scandinavian Journal of Immunology},
year = {2025},
doi = {10.1111/sji.70031}
}
EUVIMED